Novartis CEO Vas Narasimhan answers questions about COVID-19.

Zebrafish imaging sheds light on human neurological conditions.

Marjorie Eiref, Head of Operations for Neuroscience Research at Novartis, describes how her family medical history has impacted her career.

The most lethal strain could be eliminated by 2030, but major hurdles remain.

Explaining Chagas disease through the stories of patients in Bolivia.

Jennifer Allport-Anderson hunts for cardiac cures.

Gervais Tougas shares his experience working on a Novartis task force dedicated to fighting the COVID-19 pandemic.

A reversal in thinking about the reversibility of liver damage is changing the field of hepatology.

Read how a genetics postdoctoral researcher finds Huntington's mutation travels through neural circuits.

Industry labs find that, contrary to earlier evidence, KRAS-driven tumors are not addicted to autophagy.